KKR to acquire Japanese CDMO Bushu Pharmaceuticals from BPEA EQT

KKR to acquire Japanese CDMO Bushu Pharmaceuticals from BPEA EQT

American global investment company Kohlberg Kravis Roberts & Co (KKR) will acquire all shares of Bushu Pharmaceuticals from Asian private equity firm BPEA EQT for an undisclosed amount. Post-closing, KKR intends to fast-track Bushu Pharmaceuticals’ growth and further establish the company as a major contract development and manufacturing organization (CDMO) in Japan and international pharmaceutical […]

KKR wraps up $2bn acquisition of Japanese real estate asset manager MC-UBSR

KKR wraps up $2bn acquisition of Japanese real estate asset manager MC-UBSR

KKR & Co. Inc. has wrapped up the previously announced JPY230 billion (US$2 billion) acquisition of Japanese real estate asset manager Mitsubishi Corp.-UBS Realty (MC-UBSR) from Mitsubishi and UBS Asset Management. The all-cash deal was announced in March 2022. MC-UBSR has now been renamed KJR Management (KJRM). It was established in 2000 as a joint […]